Polen Capital, an investment management company, released its “Polen Global Growth Strategy” third-quarter 2024 investor ...

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...

We recently compiled a list of the 8 Best European Stocks To Buy According to Hedge Funds. In this article, we are going to ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Disruptive analytics’ Substack by Magnus Ofstad. In this article ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated ...

Novo Nordisk A/S (NYSE:NVO ... our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking ...

Ascendis Pharma and Novo Nordisk announced a partnership to develop cardiovascular ... to design novel GPCR-targeted antibody ...

Armed with a bunch of Ozempic money, the Novo Nordisk Foundation — along with Denmark’s Export and Investment fund — is ...

Novo Nordisk reports strong sales of Wegovy, propelling shares up 9%. Despite supply constraints, volumes are expected to ...